JanOne Approves Strategic Review of Biotech Assets, ALT5 Sigma Will Be Core Focus; Shares Rise Pre-Bell

MT Newswires Live07-10

JanOne (JAN) said Wednesday that its board has approved a strategic review of its biotech assets and that the recently acquired blockchain fintech provider ALT5 Sigma will become its core focus.

The company said it will explore alternatives that may include a "partial or full spin-off, entry into one or more strategic alliances, or negotiation of a partial or full sale" of the biotech assets.

ALT5 Sigma will become the company's "core engine for revenue growth," JanOne said.

As part of the realignment project, the company said it will change its name to ALT5 Sigma from JanOne and its ticker will change to "ALTS" from "JAN."

"In the short few weeks since closing the ALT5 acquisition, we have seen a significant increase in the funnel of opportunities for ALT5, which made the decision to increase the focus on that business an easy one," said JanOne Chief Executive Tony Isaac.

JanOne shares were rising past 5% in recent premarket activity.

Price: 2.0200, Change: +0.11, Percent Change: +5.76

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2450902468?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-10 21:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2450902468","market":"sg","top_or_hot":-1,"title":"JanOne Approves Strategic Review of Biotech Assets, ALT5 Sigma Will Be Core Focus; Shares Rise Pre-Bell","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/JAN\">JanOne</a> (JAN) said Wednesday that its board has approved a strategic review of its biotech assets and that the recently acquired blockchain fintech provider ALT5 Sigma will become its core focus.</p><p>The company said it will explore alternatives that may include a \"partial or full spin-off, entry into one or more strategic alliances, or negotiation of a partial or full sale\" of the biotech assets.</p><p>ALT5 Sigma will become the company's \"core engine for revenue growth,\" JanOne said.</p><p>As part of the realignment project, the company said it will change its name to ALT5 Sigma from JanOne and its ticker will change to \"ALTS\" from \"JAN.\"</p><p>\"In the short few weeks since closing the ALT5 acquisition, we have seen a significant increase in the funnel of opportunities for ALT5, which made the decision to increase the focus on that business an easy one,\" said JanOne Chief Executive Tony Isaac.</p><p>JanOne shares were rising past 5% in recent premarket activity.</p><p>Price: 2.0200, Change: +0.11, Percent Change: +5.76</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JanOne Approves Strategic Review of Biotech Assets, ALT5 Sigma Will Be Core Focus; Shares Rise Pre-Bell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJanOne Approves Strategic Review of Biotech Assets, ALT5 Sigma Will Be Core Focus; Shares Rise Pre-Bell\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-10 21:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>JanOne (JAN) said Wednesday that its board has approved a strategic review of its biotech assets and that the recently acquired blockchain fintech provider ALT5 Sigma will become its core focus.The ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2450902468","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2450902468","pubTimestamp":1720618179,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"JanOne  said Wednesday that its board has approved a strategic review of its biotech assets and that the recently acquired blockchain fintech provider ALT5 Sigma will become its core focus.The company said it will explore alternatives that may include a \"partial or full spin-off, entry into one or more strategic alliances, or negotiation of a partial or full sale\" of the biotech assets.ALT5 Sigma will become the company's \"core engine for revenue growth,\" JanOne said.As part of the realignment project, the company said it will change its name to ALT5 Sigma from JanOne and its ticker will change to \"ALTS\" from \"JAN.\"\"In the short few weeks since closing the ALT5 acquisition, we have seen a significant increase in the funnel of opportunities for ALT5, which made the decision to increase the focus on that business an easy one,\" said JanOne Chief Executive Tony Isaac.JanOne shares were rising past 5% in recent premarket activity.Price: 2.0200, Change: +0.11, Percent Change: +5.76","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"JanOne批准对生物技术资产进行战略审查，ALT5 Sigma将是核心重点；盘前股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JAN":1},"content_text":"JanOne (JAN) said Wednesday that its board has approved a strategic review of its biotech assets and that the recently acquired blockchain fintech provider ALT5 Sigma will become its core focus.The company said it will explore alternatives that may include a \"partial or full spin-off, entry into one or more strategic alliances, or negotiation of a partial or full sale\" of the biotech assets.ALT5 Sigma will become the company's \"core engine for revenue growth,\" JanOne said.As part of the realignment project, the company said it will change its name to ALT5 Sigma from JanOne and its ticker will change to \"ALTS\" from \"JAN.\"\"In the short few weeks since closing the ALT5 acquisition, we have seen a significant increase in the funnel of opportunities for ALT5, which made the decision to increase the focus on that business an easy one,\" said JanOne Chief Executive Tony Isaac.JanOne shares were rising past 5% in recent premarket activity.Price: 2.0200, Change: +0.11, Percent Change: +5.76","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2450902468"}